KoBioLabs

KoBioLabs EBITDA Margin

The EBITDA Margin of KoBioLabs (348150.KQ) as of Nov 16, 2026 is -13.93 %. In the previous year, EBITDA Margin was -8.75 % — a change of 59.20% (lower).

EBITDA Margin

-13.93 %

YoY

59.20%

Last updated:

EBITDA Margin of KoBioLabs is 2025 -13.93 % . EBITDA Margin of KoBioLabs was 2024 -8.75 % . It decreases by 59.20% lower compared to the previous year.

The KoBioLabs EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
-3,542.82 KRW
Jan 1, 2019
-1,264.12 KRW
Jan 1, 2020
-266.29 KRW
Jan 1, 2021
-560.29 KRW
Jan 1, 2022
-172.79 KRW
Jan 1, 2023
-54.40 KRW
Jan 1, 2024
-8.75 KRW
Jan 1, 2025
-13.93 KRW
The KoBioLabs EBITDA Margin history
YEAREBITDA MarginYoY
-13.93 %+59.20%
-8.75 %-83.92%
-54.40 %-68.52%
-172.79 %-69.16%
-560.29 %+110.41%
-266.29 %-78.93%
-1,264.12 %-64.32%
-3,542.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

EBITDA Margin of KoBioLabs is -13.93 % in 2025.

EBITDA Margin of KoBioLabs changed from -8.75 % to -13.93 %, representing a 59.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — KoBioLabs

All Key Metrics — KoBioLabs